JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westphal, M.
Right arrow Articles by Bone, H.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westphal, M.
Right arrow Articles by Bone, H.-G.
Related Collections
Right arrow Cardiovascular
Right arrow Critical Care
Right arrow Resuscitation
Right arrow Pharmacology

Anesth Analg 2004;99:878-885
© 2004 International Anesthesia Research Society
doi: 10.1213/01.ANE.0000131970.54062.1C


CRITICAL CARE AND TRAUMA

Dopexamine Reverses the Vasopressin-Associated Impairment in Tissue Oxygen Supply but Decreases Systemic Blood Pressure in Ovine Endotoxemia

Martin Westphal, MD, Andreas Wilhelm Sielenkämper, MD, Hugo Van Aken, MD PhD, FRCA, FANZCA, Henning Dirk Stubbe, MD, Fritz Daudel, MD, Ralf Schepers, Simone Schulte, and Hans-Georg Bone, MD

Department of Anesthesiology and Intensive Care, University of Muenster, Muenster, Germany

Address correspondence and reprint requests to Martin Westphal, MD, Klinik und Poliklinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Münster, Albert-Schweitzer-Strasse 33, 48149 Münster, Germany. Address e-mail to Martin. Westphal{at}gmx.net

Since arginine vasopressin (AVP) may reduce cardiac output and, in proportion, oxygen delivery, we studied the efficacy of dopexamine (DPX) as an adjunct to AVP infusion. After 1 h of continuous AVP infusion (0.04 U/min) in healthy sheep (n = 7), DPX was additionally administered in incremental doses (1, 5, and 10 µg · kg–1 · min–1; each dose for 30 min). After a 24-h period of recovery, endotoxin was continuously infused in the same sheep to induce and maintain a hypotensive/hyperdynamic circulation. After 16 h of endotoxemia, AVP and DPX were given as described previously. AVP infusion increased systemic vascular resistance index and decreased cardiac index in both healthy and endotoxemic conditions (P < 0.001 each). This was accompanied by an augmented pulmonary vascular resistance index in endotoxemia (159 ± 13 dynes · cm–5 · m–2 versus 202 ± 16 dynes · cm–5 · m–2) and a decrease in oxygen delivery index (health: 842 ± 66 mL · min–2 · m–2 versus 475 ± 38 mL · min–2 · m–2; endotoxemia: 1073 ± 49 mL · min–2 · m–2 versus 613 ± 44 mL · min–2 · m–2) and mixed venous oxygen content (health: 63% ± 2% versus 47% ± 2%; endotoxemia: 68% ± 2% versus 51% ± 3%; P < 0.001 each). Small doses of DPX (1 and 5 µg · kg–1 · min–1) improved not only the AVP-associated depressions in cardiac index, oxygen delivery index, and mixed venous oxygen content, but also the pulmonary vasopressive effect in both groups. While large-dose DPX (10 µg · kg–1 · min–1) also reduced mean pulmonary arterial pressure in endotoxemia (27 ± 1 mm Hg versus 23 ± 1 mm Hg; P < 0.05 versus baseline), mean arterial blood pressure decreased (105 ± 4 mm Hg versus 80 ± 3 mm Hg) and heart rate increased (84 ± 4 bpm versus 136 ± 9 bpm; P < 0.001 versus AVP alone), thereby limiting its therapeutic use.

IMPLICATIONS: Because vasopressin decreases cardiac output and oxygen delivery, we investigated the use of dopexamine as an adjunct to vasopressin infusion. During experimental endotoxemia, small doses of dopexamine reversed the arginine vasopressin-linked depression in cardiac index, thereby improving oxygen supply. Although large-dose dopexamine (10 µg · kg–1 · min–1) improved the pulmonary circulation, systemic hypotension and tachycardia occurred.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Morelli, C. Ertmer, M. Lange, M. Dunser, S. Rehberg, H. Van Aken, P. Pietropaoli, and M. Westphal
Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study
Br. J. Anaesth., April 1, 2008; 100(4): 494 - 503.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Stolz, M. Christ-Crain, N. G. Morgenthaler, J. Leuppi, D. Miedinger, R. Bingisser, C. Muller, J. Struck, B. Muller, and M. Tamm
Copeptin, C-Reactive Protein, and Procalcitonin as Prognostic Biomarkers in Acute Exacerbation of COPD
Chest, April 1, 2007; 131(4): 1058 - 1067.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. Lange, K. Broking, C. Hucklenbruch, C. Ertmer, H. Van Aken, M. Lucke, H.-G. Bone, and M. Westphal
Hemodynamic effects of titrated norepinephrine in healthy versus endotoxemic sheep
Innate Immunity, February 1, 2007; 13(1): 53 - 57.
[Abstract] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2004 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2004 by the International Anesthesia Research Society.